Psykey, Inc. (CEOS) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Instruments & Supplies 行业. 公司总部位于 Toronto, ON, 加拿大. 现任CEO为 Michael Maher.
CEOS 拥有 IPO日期为 2006-02-14, 6 名全职员工, 在 Other OTC, 市值为 $124.89K.
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.
